文献速递神经MRPET

小血管病与帕金森病病理之间的相互作用:一项纵向研究

The interplay between small vessel disease and Parkinson disease pathology: A longitudinal study.
PubMed 文献 · Eur J Radiol · 2022-07-21

该纵向研究基于PPMI数据库纳入114例帕金森病患者和66例健康对照,用PSMD反映血管病理、DAT显像反映多巴胺能神经元变性。基线PSMD在两组间无显著差异(P=0.169);PD患者基线PSMD较高与尾状核DAT减少较少相关(β=0.216,P=0.029),而基线DAT可用性与PSMD进展无显著关联。结论提示轻度小血管病可能减缓帕金森病病理进展,而帕金森病病理对小血管病进展的影响不显著。

要点

  • 基线PSMD在帕金森病与健康对照间无显著差异(P=0.169)。
  • PD患者基线PSMD较高与尾状核DAT减少较少相关(β=0.216,P=0.029)。
  • 基线尾状核和壳核DAT可用性与PSMD进展无显著关联(P=0.950;P=0.860)。

核心结论

  • 轻度小血管病可能减缓帕金森病病理进展,而帕金森病病理对小血管病进展的影响不显著。

研究设计与样本

  • 纵向研究,从帕金森病进展标志物计划(PPMI)数据库筛选66例健康对照和114例帕金森病患者,基线及24个月随访时从弥散张量图像量化骨架化平均弥散率峰值宽度(PSMD)反映血管病理,同时间点用多巴胺转运体(DAT)显像代表多巴胺能神经元变性程度。

诊断标准与关键数值

  • 基线PSMD在健康对照与帕金森病患者间无显著差异(P=0.169)。
  • 帕金森病患者基线PSMD较高与尾状核DAT减少较少相关(β=0.216,P=0.029),与壳核DAT减少无显著关联(β=0.058,P=0.552)。
  • 帕金森病患者基线尾状核DAT可用性与PSMD进展无显著关联(β=-0.006,P=0.950),基线壳核DAT可用性与PSMD进展亦无显著关联(β=0.017,P=0.860)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Cerebral small vessel disease (SVD) related brain changes have been found associated with various clinical symptoms of Parkinson disease (PD). On the other hand, PD pathology and treatment may also accelerate SVD progression.

OBJECTIVE: The aim of this study is to explore the interplay between SVD and PD pathology using longitudinal dataset.

METHODS: We screened 66 healthy controls (HCs) and 114 patients from the Parkinson Progression Markers Initiative (PPMI) database. The peak width of skeletonized mean diffusivity (PSMD) was quantified from diffusion tensor images to reflect vascular pathologies at baseline and 24 months follow-up, and dopamine transporter (DAT) imaging data was used to represent the extent of dopaminergic neuronal degeneration at the same point time. We compared the PSMD between PD patients and HCs, and analyzed whether PSMD and DAT availability could predict each other's progression using multiple regression analyses in PD patients.

RESULTS: PSMD at baseline had no significant difference between the HCs and patients with PD (P = 0.169). Higher baseline PSMD was associated with less DAT reduction in the caudate (β = 0.216, P = 0.029), but not the putamen (β = 0.058, P = 0.552) in PD patients. Baseline caudate and putamen DAT availability had no significant association with PSMD progression (β = -0.006, P = 0.950; β = 0.017, P = 0.860, respectively).

CONCLUSIONS: Mild SVD might slow down PD pathology progression, while the effect of PD pathology on the progression of SVD was not significant.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Mao, Zhang, Zou, et al. The interplay between small vessel disease and Parkinson disease pathology: A longitudinal study. Eur J Radiol. 2022. PMID: 35907289. doi:10.1016/j.ejrad.2022.110441

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。